|
|
|
|
Science Sparks @ ACTREC
|
 10 November 2025 |
Vol. No. 14 ; Issue No.708 |
|
|
Publications
|
|
1. Patnaik C, Rath S, De A (2025). Avenues for integrating photothermal therapy in cancer clinic. Communications Chemistry. 8(1):324.
2. Gandhi KA, Chaubal R, Talker E, Aadhi JC, Pandey S, Mukhare R, Kadam A, Singh A, Gurav M, Parab P, Kembhavi Y, Thorat R, Sekar A, Gulia S, Gala K, Shetty N, Joshi S, Kulkarni S, Shet T, Gupta S (2025). Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients. Scientific Reports. 15(1):38610.
3. Samantaray SS, Patra P, Panda SS, Panda P, Dash BK, Patil SP, Budukh AM (2025). Management of tobacco pouch keratosis in the tribal area of Mayurbhanj, India. Canadian Journal of Dental Hygiene. 59(3):224-227
4. Raj JAT, John G, Ghanekar S, Thiruselvan GK, Shah J, Ande D, Chatterjee A, Goda JS (2025). RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications. Brain Research. 1869: 150026.
5. Shaikh ZM, Banerji S, Sunil S, Zachariah A, Aradhye P, Anbarasu A, Gawde J, Kaushal RK, Yadav S, Thorat R, Mahimkar MB (2025). Comprehensive macroscopic, histopathological, and molecular assessment of B[a]P and NNK-induced lung tumours in A/J mice reveals no chemopreventive efficacy of Thearubigins. Biochemical and Biophysical Research Communications. 791:152951.
|
|
|
|
|
Interesting Reads
|
|
Bachem A, Clarke M, Kong G, Tarasova I, Dryburgh L, Kosack L, Lee AR, Newland LD, Wagner T, Bawden E, Yap KM, Wilson MD, Engel S, Wilson KR, Russ BE, Tandon K, Lau PKH, McArthur G, Marcelino VR, Beavis PA, Turner SJ, Waithman J, Stinear TP, Sandhu S, Schröder J, Gebhardt T, Bedoui S (2025). Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma. Immunity.
|
|
|
Video of the Week
|
|
| Transforming Early Cancer Detection with EHR and AI |
|
| |
|
|
| |
|
|
Upcoming Events
|
| |
|
|
| |
|
|
|
|
| |
|
ONCOSURG 2025
|
|
November 20-22, 2025
|
|
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
|
|
|
| |
|
|
Do You Know?
In 1997, FDA approved Rituxan (rituximab), the first monoclonal antibody, to treat non-Hodgkin’s lymphoma.
|
|
|
|
Cancer News
|
| |
|
Scientists Create First-Ever Drug to Destroy Cancer’s “Immortality” RNA
|
|
SciTechDaily, 07/11/2025
|
|
Researchers have designed a groundbreaking drug molecule capable of precisely eliminating TERRA, an RNA molecule that some cancer cells rely on to survive. Using a sophisticated method known as “RIBOTAC” technology, the new compound seeks out TERRA within cells and destroys it...
|
| |
|
Lung cancer's earliest stages may be driven by inflammation.
|
|
MedicalXpress, 06/11/2025
|
|
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers have discovered that the earliest stages of lung cancer may be driven by inflammation, suggesting that targeting proinflammatory pathways could be an early...
|
|
|
|
|
| |
|
|
|
Radiotherapy after mastectomy can be avoided, study finds
|
|
Eurekalert, 05/11/2025
|
|
Radiotherapy had minimal impact on cancer recurring at the site of mastectomy. Nine patients who received the treatment saw their breast cancer return on the chest wall, compared with 20 who did not. Side effects from radiotherapy were mild with no excess deaths reported from cardiac causes...
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
